Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simultaneous measurement of nascent transcriptome and translatome using 4-thiouridine metabolic RNA labeling and translating ribosome affinity purification. | Nucleic Acids Res | 2023 | 37378452 | PubTator, text mining | PubMed |
| Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer. | Front Oncol | 2023 | 37377907 | PubTator, text mining | PubMed |
| Subviral Dense Bodies of Human Cytomegalovirus Enhance Interferon-Beta Responses in Infected Cells and Impair Progeny Production. | Viruses | 2023 | 37376632 | PubTator, text mining | PubMed |
| CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9. | Pathogens | 2023 | 37375504 | PubTator, text mining | PubMed |
| Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37373553 | PubTator, text mining | PubMed |
| Generation and Characterization of a Zebrafish Model for ADGRV1-Associated Retinal Dysfunction Using CRISPR/Cas9 Genome Editing Technology. | Cells | 2023 | 37371069 | PubTator, text mining | PubMed |
| Eupatilin Improves Cilia Defects in Human CEP290 Ciliopathy Models. | Cells | 2023 | 37371046 | PubTator, text mining | PubMed |
| Structural analysis of mitochondrial rRNA gene variants identified in patients with deafness. | Front Physiol | 2023 | 37362424 | PubTator, text mining | PubMed |
| Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer. | NPJ Precis Oncol | 2023 | 37353681 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| Successful large gene augmentation of USH2A with non-viral episomal vectors. | Mol Ther | 2023 | 37337429 | PubTator, text mining | PubMed |
| A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer. | BMC Med Genomics | 2023 | 37337170 | PubTator, text mining | PubMed |
| Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2a. | Ophthalmol Sci | 2023 | 37334034 | PubTator, text mining | PubMed |
| A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts. | Front Immunol | 2023 | 37325647 | PubTator, text mining | PubMed |
| Hydroxychloroquine-induced Retinal Toxicity. | Front Pharmacol | 2023 | 37324471 | PubTator, text mining | PubMed |
| Next-generation sequencing--based genetic testing and phenotype correlation in retinitis pigmentosa patients from India. | Indian J Ophthalmol | 2023 | 37322672 | PubTator, text mining | PubMed |
| A pangenome reference of 36 Chinese populations. | Nature | 2023 | 37316654 | PubTator, text mining | PubMed |
| A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa. | Mol Ther Nucleic Acids | 2023 | 37313440 | PubTator, text mining | PubMed |
| Detailed analysis of an enriched deep intronic ABCA4 variant in Irish Stargardt disease patients. | Sci Rep | 2023 | 37296172 | PubTator, text mining | PubMed |
| Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease? | Front Mol Neurosci | 2023 | 37293541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=17